Skip to content
healthcare.dev

LACOSAMIDE

NDC 68462-697, LACOSAMIDE, injection, solution, from GLENMARK PHARMACEUTICALS INC., USA.

Product NDC
68462-697
Status
Listed
Labeler
GLENMARK PHARMACEUTICALS INC., USA
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA220268
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-697 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE10 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
68462-697-306846206973010 VIAL in 1 CARTON (68462-697-30) / 20 mL in 1 VIAL (68462-697-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc

Use it

Look up 68462-697 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-697 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-697. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.